2014
DOI: 10.1038/ncomms5335
|View full text |Cite
|
Sign up to set email alerts
|

An ALS-associated mutation in the FUS 3′-UTR disrupts a microRNA–FUS regulatory circuitry

Abstract: While the physiologic functions of the RNA-binding protein FUS still await thorough characterization, the pathonegetic role of FUS mutations in amyotrophic lateral sclerosis (ALS) is clearly established. Here we find that a human FUS mutation that leads to increased protein expression, and was identified in two ALS patients with severe outcome, maps to the seed sequence recognized by miR-141 and miR-200a in the 3 0 -UTR of FUS. We demonstrate that FUS and these microRNAs are linked by a feed-forward regulatory… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
95
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 108 publications
(99 citation statements)
references
References 31 publications
4
95
0
Order By: Relevance
“…Therefore, it is tempting to speculate that mutations disrupting the protein structure may not only be completely responsible for the disease but also changes in FUS protein levels. In fact, mutations in the 3′-UTR of the FUS gene that lead to increased FUS levels through an altered feed-forward regulatory loop, are associated with ALS (Dini Modigliani et al, 2014), suggesting that FUS has to be properly regulated to avoid pathology. Non-neuronal cells, which do not recapitulate the complexity of neurons, as well as neurons have also been extensively used in vitro as valuable tools to analyze cell specific responses but only by overexpressing WT or mFUS (Dormann et al, 2010; Bentmann et al, 2012; Jäckel et al, 2014).…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, it is tempting to speculate that mutations disrupting the protein structure may not only be completely responsible for the disease but also changes in FUS protein levels. In fact, mutations in the 3′-UTR of the FUS gene that lead to increased FUS levels through an altered feed-forward regulatory loop, are associated with ALS (Dini Modigliani et al, 2014), suggesting that FUS has to be properly regulated to avoid pathology. Non-neuronal cells, which do not recapitulate the complexity of neurons, as well as neurons have also been extensively used in vitro as valuable tools to analyze cell specific responses but only by overexpressing WT or mFUS (Dormann et al, 2010; Bentmann et al, 2012; Jäckel et al, 2014).…”
Section: Discussionmentioning
confidence: 99%
“…Over the last decade, TDP-43, FUS, Matrin-3, VCP and several other RNA-binding proteins have been found to be linked with causing ALS pathogenesis suggesting that disease-causing mutations perturbing RNA metabolism might be central to causing ALS pathogenesis [26, 51, 52, 64, 68]. This is supported by recent studies showing that ALS-causing mutations in RNA binding proteins cause defects in RNA splicing, stability, transcription, mRNA processing, translation and transport, which may lead to gross functional impairments in several key biological pathways [3, 57, 10, 1823, 25, 30, 31, 33, 34, 60, 61, 63, 65, 66]. …”
Section: Introductionmentioning
confidence: 92%
“…FUS binds RNA and shuttles between the nucleus and the cytoplasm, participating in nucleo-cytoplasmic RNA shuttling [9]. FUS also plays roles in DNA repair [1012], transcription [1323], RNA splicing [22, 24, 25], dendritic RNA transport [2628] and miRNA biogenesis and function [29, 30]. However, the physiological functions of FUS are still not fully understood.…”
Section: Introductionmentioning
confidence: 99%